The role of the data safety and monitoring committee in stroke trials

被引:3
|
作者
Asplund, K [1 ]
机构
[1] Univ Hosp, Dept Med, SE-90185 Umea, Sweden
关键词
data safety and monitoring committee; sponsoring of trials; patient recruitment; steering committee;
D O I
10.1159/000068511
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are many good reasons why any human experiment should have appropriate oversight. In clinical trials, the data safety and monitoring committee (DSMC) serves to protect the interests of the patients. In stroke trials, its members usually together represent a broad expertise in neurology, internal medicine, cardiology and biostatistics. Independency and integrity are key words, especially in the relationship to the sponsor of the trial. The DSMC members should have no long-term financial strings to the sponsor, and they should not be personally involved in patient recruitment and evaluation. The DSMC provides recommendations to the steering committee of the trial on whether to continue or to stop patient recruitment and on protocol amendments that may be necessary to protect the safety of the patients. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 50 条
  • [1] Role of the Data and Safety Monitoring Committee (DSMC)
    Wilhelmsen, L
    STATISTICS IN MEDICINE, 2002, 21 (19) : 2823 - 2829
  • [2] Should all trials have a Data Safety and Monitoring Committee?
    Cairns, JA
    Hallstrom, A
    Held, P
    AMERICAN HEART JOURNAL, 2001, 141 (01) : 156 - 163
  • [3] Risks in Randomized Controlled Trials: Role of Interim Analysis and Data Monitoring Committee
    Naqvi, Haider A.
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2015, 25 (08): : 557 - 559
  • [4] The role of data and safety monitoring board in clinical trials: A systematic review
    Li, LC
    Hutton, E
    Jong, P
    Ross, S
    Hannah, M
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1883 - 1883
  • [5] Data Safety Monitoring BoardsTheir Role in Drug Development and Pharmaceutical Trials
    Hugh Boardman
    International Journal of Pharmaceutical Medicine, 2003, 17 (1) : 39 - 46
  • [6] The role of data and safety monitoring boards in implementation trials: When are they justified?
    Fiscella, Kevin
    Sanders, Mechelle
    Holder, Tameir
    Carroll, Jennifer K.
    Luque, Amneris
    Cassells, Andrea
    Johnson, Brent A.
    Williams, Stephen K.
    Tobin, Jonathan N.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 4 (03) : 229 - 232
  • [7] Data and safety monitoring of rosiglitazone trials
    Nabel, Eliozabeth G.
    Shurin, Susan B.
    Simons-Morton, Denise G.
    Gordon, David
    LANCET, 2007, 369 (9579): : 2077 - 2077
  • [8] The Data and Safety Monitoring Committee: Some final thoughts
    DeMets, DL
    Yusuf, S
    AMERICAN HEART JOURNAL, 2001, 141 (04) : 548 - 549
  • [9] Key role of the safety committee in long term intervention trials
    Lichtlen, PR
    Kopcke, W
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1997, : 69 - 71
  • [10] The Necessity of Independent Data Monitoring Committee in Domestic Clinical Trials
    Kang, Seung-Ho
    KOREAN JOURNAL OF APPLIED STATISTICS, 2009, 22 (02) : 317 - 327